Stefan Oelrich - Bayer AG Head Management

All Insiders . Germany . 
Stock . Bayer AG NA . Stakeholders . Insider . Stefan Oelrich
BAYN Stock  EUR 21.85  0.63  2.97%   

Insider

Stefan Oelrich is Head Management of Bayer AG NA
Age 55
Phone49 214 30 1
Webhttps://www.bayer.com

Bayer AG Management Efficiency

The company has return on total asset (ROA) of 0.0576 % which means that it generated a profit of $0.0576 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.13 %, meaning that it generated $0.13 on every $100 dollars invested by stockholders. Bayer AG's management efficiency ratios could be used to measure how well Bayer AG manages its routine affairs as well as how well it operates its assets and liabilities.
Bayer AG NA has accumulated 35.55 B in total debt with debt to equity ratio (D/E) of 1.17, which is about average as compared to similar companies. Bayer AG NA has a current ratio of 1.16, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Bayer AG until it has trouble settling it off, either with new capital or with free cash flow. So, Bayer AG's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bayer AG NA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bayer to invest in growth at high rates of return. When we think about Bayer AG's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Damian FinioPhibro Animal Health
53
Jonathan BendheimPhibro Animal Health
47
Joseph HoganAlign Technology
66
Emory WrightAlign Technology
53
Christopher HunterAcadia Healthcare
55
John MoriciAlign Technology
56
Andrew HoneyboneAcadia Healthcare
N/A
Stuart HockridgeAlign Technology
51
Shirley StacyAlign Technology
N/A
Zelko RelicAlign Technology
58
Vamsi PudipeddiAlign Technology
51
Simon BeardAlign Technology
56
Ramon FuenmayorPhibro Animal Health
N/A
David CFAAcadia Healthcare
N/A
Isa DiazAcadia Healthcare
N/A
E CorcoranPhibro Animal Health
72
Anthony AndolinoPhibro Animal Health
50
Gretchen HommrichAcadia Healthcare
N/A
MD JDAcadia Healthcare
N/A
Laurence HarrodAcadia Healthcare
66
Jennifer OlsonWilkAlign Technology
45
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. BAYER AG is traded on Frankfurt Stock Exchange in Germany. Bayer AG NA (BAYN) is traded on Frankfurt Exchange in Germany and employs 102,296 people.

Management Performance

Return On Equity0.13
Return On Asset0.0576

Bayer AG NA Leadership Team

Elected by the shareholders, the Bayer AG's board of directors comprises two types of representatives: Bayer AG inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bayer. The board's role is to monitor Bayer AG's management team and ensure that shareholders' interests are well served. Bayer AG's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bayer AG's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sarena Lin, Labor Officer
Oliver Maier, Head Relations
Gabriel Harnier, Patents Law
Heiko Schipper, Member Division
Rodrigo Santos, Member Division
Michael Preuss, Gov Communications
Stefan Oelrich, Head Management
Wolfgang Nickl, CFO Board
BerndPeter Bier, Head Taxes
Werner Baumann, CEO Board

Bayer Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bayer AG a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.13
Return On Asset0.0576
Profit Margin0.09 %
Operating Margin0.23 %
Current Valuation83.74 B
Shares Outstanding982.42 M
Shares Owned By Institutions47.06 %
Price To Earning11.34 X
Price To Book1.37 X
Price To Sales1.00 X

Currently Active Assets on Macroaxis

EBRCentrais Electricas Brasileiras
HEHawaiian Electric Industries
VFCVF Corporation
BVHMFVistry Group PLC
SSentinelOne

Other Information on Investing in Bayer Stock

Bayer AG financial ratios help investors to determine whether Bayer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer AG security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY